-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1245 Price Target

Benzinga·04/07/2026 11:01:22
Listen to the news
HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $1245 price target.